3114.0: Monday, November 13, 2000 - 2:30 PM

Abstract #17383

Prescription Drugs as a Public Good: Market and Regulatory Implications

Stephen W. Schondelmeyer, PharmD, PhD, PRIME Institute, University of Minnesota College of Pharmacy, 308 Harvard Street, SE, Weaver-Densford Hall, 7-159, Minneapolis, MN 55455, 612 624 9931, schon001@maroon.tc.umn.edu

Learning Objectives: Identify methods of financing prescription drug coverage. Describe market and regulatory options for making prescription drugs more affordable

Keywords: Access to Care, Drugs

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 128th Annual Meeting of APHA